Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 3 40-3, 1996, Pages

  Zagon, Ian S ^a,b   Hytrek, Staci D ^a   McLaughlin, Patricia J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

cancer; gastrointestinal tract; growth regulation; neoplasia; peptides

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; METENKEPHALIN; N ALLYLNORMETAZOCINE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALTREXONE; OPIATE AGONIST; OPIOID GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DISSOCIATION CONSTANT; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0029823510     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.3.r511     Document Type: Article

References (31)

1. Anzano, M. A., D. Rieman, W. Prichett, D. F. Bowen-Pope, and R. Grieg. Growth factor production by human colon carcinoma cell lines. Cancer Res. 49: 2898-2904, 1989.
2. Barg, J., M. Belcheva, R. McHale, R. Levy, Z. Vogel, and C. J. Coscia. β-Endorphin is a potent inhibitor of thymidine incorporation into DNA via μ- and κ-opioid receptors in fetal rat brain cell aggregates in culture. J. Neurochem. 60: 765-767, 1993.
3. Bartolome, J. V., M. B. Bartolome, B. A. Lorber, S. J. Dileo, and S. M. Schanberg. Effects of central administration of beta-endorphin on brain and liver DNA-synthesis in preweanling rats. Neuroscience 40: 289-294, 1991.
4. Bem, W. T., G. E. Thomas, J. Y. Mamone, S. M. Homan, B. K. Levy, F. E. Johnson, and C. J. Coscia. Overexpression of σ-receptors in nonneural human tumors. Cancer Res. 51: 6558-6562, 1991.
5. Boland, C. R. The biology of colorectal cancer. Cancer 71, Suppl.: 4180-4186, 1993.
6. Boring, C. C., T. S. Squires, and T. Tong. Cancer statistics. CA Cancer J. Clin. 42: 19-38, 1992.
7. Bostwick, D. G., W. E. Null, D. Holmes, E. Weber, J. D. Barchas, and K. G. Bensch. Expression of opioid peptides in tumors. N. Engl. J. Med. 317: 1439-1443, 1987.
8. Brent, P. J., and G. T. Pang. σ-Binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture. Eur. J. Pharmacol. 278: 151-160, 1995
9. Chen, T. R., D. Drabkowski, R. J. Hay, M. Macy, and W. Peterson. WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. Cancer Genet. Cytogenet. 27: 125-134, 1987.
10. Ciardiello, F., N. Kim, T. Saeki, R. Dono, M. G. Persico, G. D. Plowman, J. Garrigues, S. Radke, G. J. Todaro, and D. S. Salomon. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. Natl. Acad. Sci. USA 88: 7792-7796, 1991.
11. Coffey, R. J., G. D. Shipley, and H. L. Moses. Production of transforming growth factors by human colon cancer lines. Cancer Res. 46: 1164-1169, 1986.
12. Culouscou, J.-M., M. Remacle-Bonnet, F. Garrouste, J. Fantini, J. Marvaldi, and G. Pommier. Production of insulin-like growth factor II (IGF-II) and different forms of IGF-binding proteins by HT-29 human colon carcinoma cell line. J. Cell. Physiol. 143: 405-415, 1990.
13. Ferri, G.-L., A. Watkinson, and G. J. Dockray. Proenkephalin A-derived peptides in the human gut. Gastroenterology 95: 1011-1017. 1988.
14. Fogh, J., and G. Trempe. New human tumor cell lines. In: Human Tumor Cells In Vitro, edited by J. Fogh. New York: Plenum, 1975. p. 115-159.
15. Huang, S., J. M. Trujillo, and S. Chakrabarty. Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor α. Int. J. Cancer 52: 978-986, 1992.
16. Hytrek, S. D., C. M. Lang, J. P. Smith, P. J. McLaughlin, and I. S. Zagon. Opioid growth factor modulates tumongenesis of human colon carcinoma grown in nude mice (Abstract). Gastroenterology 108: A483, 1995.
17. Hytrek, S. D., P. J. McLaughlin, C. M. Lang, and I. S. Zagon. Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone. Cancer Lett. 101: 159-164, 1996.
18. Hytrek, S. D., J. P. Smith, T. J. McGarrity, P. J. McLaughlin, C. M. Lang, and I. S. Zagon. Identification and characterization of the ζ-opioid receptor in human colon cancer. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R115-R121, 1996.
19. Iishi, H., M. Tatsuta, M. Baba, S. Okuda, and H. Taniguchi. Enhancement by methionine enkephalin of colon carcinogenesis induced by azoxymethane. Cancer Res. 51: 785-788, 1991.
20. Leslie, F. M. Methods used for the study of opioid receptors. Pharmacol. Rev. 39: 197-249, 1987.
21. Markowitz, S. D., K. Molkentin, C. Gerbic, J. Jackson, T. Stellato, and J. K. Willson. Growth stimulation by coexpression of transforming growth factor-α and epidermal growth factor-receptor in normal and adenomatous human colon epithelium. J. Clin. Invest. 86: 356-362, 1990.
22. Meriney, S. D., M. J. Ford, D. Oliva, and G. Pilar. Endogenous opioids modulate neuronal survival in the developing avian ciliary ganglion. J. Neurosci. 11: 3705-3717, 1991.
23. Murgo, A. J. Inhibition of B16-BL6 melanoma growth in mice by methionine-enkephalin. J. Natl. Cancer Inst. 75: 341-344, 1985.
24. Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern, and M. B. Sporn. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82: 119-123, 1985.
25. Semple, T. U., L. A. Quinn, L. K. Woods, and G. E. Moore. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res. 38: 1345-1355, 1978.
26. Smith, J. P., S. T. Kramer, and L. M. Demers. Effects of gastrin and difluoromethylornithine on growth of human colon cancer. Dig. Dis. Sci. 38: 520-528, 1993.
27. Tari, A., Y. Miyachi, K. Sumii, K. Haruma, M. Yoshihara, G. Kajiyama, and A. Miyoshi. β-Endorphin-like immunoreactivity in normal mucosa, muscle layer, adenocarcinoma, and polyp of the colon. Dig. Dis. Sci. 33: 429-434, 1988.
28. Villiger, P. M., and M. Lotz. Expression of prepro-enkephalin in human articular chondrocytes is linked to cell proliferation. EMBO J. 11: 135-143, 1992.
29. Zagon, I. S., and P. J. McLaughlin. The role of endogenous opioids and opioid receptors in human and animal cancers. In: Stress and Immunity, edited by N. P. Plotnikoff, A. J. Murgo, R. E. Faith, and J. Wybran. Caldwell, NJ: CRC, 1991, p. 343-356.
30. Zagon, I. S., P. J. McLaughlin, S. R. Goodman, and R. E. Rhodes. Opioid receptors and endogenous opioids in diverse human and animal cancers. J. Natl. Cancer Inst. 79: 1059-1065, 1987.
31. Zagon, I. S., J. W. Sassani, and P. J. McLaughlin. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture. Am. J. Physiol. 268 (Regulatory Integrative Comp. Physiol. 37): R942-R950, 1995.